Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.

作者: Gordon Cook , A John Ashcroft , Guy Pratt , Rakesh Popat , Karthik Ramasamy

DOI: 10.1111/BJH.16874

关键词:

摘要:

参考文章(14)
Benjamin W. Teh, Leon J. Worth, Simon J. Harrison, Karin A. Thursky, Monica A. Slavin, Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital. Supportive Care in Cancer. ,vol. 23, pp. 1901- 1906 ,(2015) , 10.1007/S00520-014-2550-3
Luciano J. Costa, Ilene K. Brill, James Omel, Kelly Godby, Shaji K. Kumar, Elizabeth E. Brown, Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Advances. ,vol. 1, pp. 282- 287 ,(2017) , 10.1182/BLOODADVANCES.2016002493
Noa Lavi, Irit Avivi, Zipora Kra-Oz, Ilana Oren, Emilia Hardak, Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma Supportive Care in Cancer. ,vol. 26, pp. 2425- 2431 ,(2018) , 10.1007/S00520-018-4079-3
Andrew J Cowan, Christine Allen, Aleksandra Barac, Huda Basaleem, Isabela Bensenor, Maria Paula Curado, Kyle Foreman, Rahul Gupta, James Harvey, H Dean Hosgood, Mihajlo Jakovljevic, Yousef Khader, Shai Linn, Deepesh Lad, Lorenzo Mantovani, Vuong Minh Nong, Ali Mokdad, Mohsen Naghavi, Maarten Postma, Gholamreza Roshandel, Katya Shackelford, Mekonnen Sisay, Cuong Tat Nguyen, Tung Thanh Tran, Bach Tran Xuan, Kingsley Nnanna Ukwaja, Stein Emil Vollset, Elisabete Weiderpass, Edward N Libby, Christina Fitzmaurice, None, Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016 JAMA Oncology. ,vol. 4, pp. 1221- 1227 ,(2018) , 10.1001/JAMAONCOL.2018.2128
Moritz Binder, S. Vincent Rajkumar, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Angela Dispenzieri, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Suzanne R. Hayman, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, Shaji K. Kumar, Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma American Journal of Hematology. ,vol. 94, pp. 306- 311 ,(2018) , 10.1002/AJH.25365
Rodrigo Carlini Fernando, Diego Robles Mazzotti, Hatylas Azevedo, Alex Freire Sandes, Edgar Gil Rizzatti, Mariana Bleker de Oliveira, Veruska Lia Fook Alves, Angela Isabel Pereira Eugênio, Fabrício de Carvalho, Maria Aparecida Dalboni, David Correa Martins, Gisele Wally Braga Colleoni, None, Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism. Scientific Reports. ,vol. 9, pp. 1056- ,(2019) , 10.1038/S41598-018-38314-8
Ola Landgren, Jonathan N. Hofmann, Charlene M. McShane, Loredana Santo, Malin Hultcrantz, Neha Korde, Sham Mailankody, Dickran Kazandjian, Kazunori Murata, Katie Thoren, Lakshmi Ramanathan, Ahmet Dogan, Even Rustad, Sydney X. Lu, Theresia Akhlaghi, Sigurdur Y. Kristinsson, Magnus Björkholm, Sean Devlin, Mark P. Purdue, Ruth M. Pfeiffer, Ingemar Turesson, Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. JAMA Oncology. ,vol. 5, pp. 1293- 1301 ,(2019) , 10.1001/JAMAONCOL.2019.1568
Mark T Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire T Hulme, Irene Monahan, Kamaraj Karunanithi, Helen Dignum, Edward Belsham, Jeff Neilson, Beth Harrison, Anand Lokare, Gavin Campbell, Michael Hamblin, Peter Hawkey, Anna C Whittaker, Eric Low, Janet A Dunn, Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial Lancet Oncology. ,vol. 20, pp. 1760- 1772 ,(2019) , 10.1016/S1470-2045(19)30506-6
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu, Zhenshun Cheng, Ting Yu, Jiaan Xia, Yuan Wei, Wenjuan Wu, Xuelei Xie, Wen Yin, Hui Li, Min Liu, Yan Xiao, Hong Gao, Li Guo, Jungang Xie, Guangfa Wang, Rongmeng Jiang, Zhancheng Gao, Qi Jin, Jianwei Wang, Bin Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China The Lancet. ,vol. 395, pp. 497- 506 ,(2020) , 10.1016/S0140-6736(20)30183-5
Ajai Chari, Paul G. Richardson, Dorothy Romanus, Meletios A. Dimopoulos, Pieter Sonneveld, Evangelos Terpos, Roman Hajek, Aditya Raju, Antonio Palumbo, Lauren E. Cain, Marlo Blazer, Hui Huang, Eileen Farrelly, Sikander Ailawadhi, Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd. Expert Review of Hematology. ,vol. 13, pp. 421- 433 ,(2020) , 10.1080/17474086.2020.1729734